¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"MI"¿¡ ´ëÇÑ Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
5
ÆäÀÌÁö:
8
ÄÚµå
¿µ¹®
ÇѱÛ
Y54.1
Mineralocorticoid antagonists [aldosterone antagonists]
¹Ì³×¶ö·ÎÄÚÆ¼ÄÚÀÌµå ´ëÇ×Á¦(±æÇ×Á¦)[¾Ëµµ½ºÅ×·Ð ´ëÇ×Á¦(±æÇ×Á¦)]
T50.0
Mineralocorticoids and their antagonists
¿°·ùÄÚ¸£Æ¼ÄÚÀÌµå ¹× ´ëÇ×Á¦(±æÇ×Á¦)
N00.0
Minor glomerular abnormality
¼Ò »ç±¸Ã¼ ÀÌ»ó
N01.0
Minor glomerular abnormality
¼Ò »ç±¸Ã¼ ÀÌ»ó
N02.0
Minor glomerular abnormality
¼Ò »ç±¸Ã¼ ÀÌ»ó
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½